The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

• Status: Recruiting
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is performed to evaluate the efficacy and safety of various measures in the treatment of HSPN with mild proteinuria in children.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nanjing Children's Hospital
• Treatments: Benazepril; Prednisone

Criteria

Inclusion Criteria:

• Renal biopsy proved HSPN (ISKDC class II)

• Proteinuria < 25 mg/kg/d

Exclusion Criteria:

• The children with congenital diseases

• Proteinuria≥25 mg/kg/d